Filana Therapeutics, Inc. (FLNA)
FLNA Stock Price Chart
Explore Filana Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze FLNA price movements and trends.
FLNA Company Profile
Discover essential business fundamentals and corporate details for Filana Therapeutics, Inc. (FLNA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
14 Jul 2000
Employees
20.00
Website
https://www.filanatx.comCEO
Richard Jon Barry
Description
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
FLNA Financial Timeline
Browse a chronological timeline of Filana Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.23.
Earnings released on 7 May 2026
EPS came in at -$0.21 surpassing the estimated -$0.23 by +8.70%.
Earnings released on 12 Mar 2026
EPS came in at -$0.26 surpassing the estimated -$0.30 by +13.33%.
FLNA Stock Performance
Access detailed FLNA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
